País: Estados Unidos
Língua: inglês
Origem: NLM (National Library of Medicine)
CIPROFLOXACIN (UNII: 5E8K9I0O4U) (CIPROFLOXACIN - UNII:5E8K9I0O4U)
STAT RX USA LLC
CIPROFLOXACIN
CIPROFLOXACIN 750 mg
ORAL
PRESCRIPTION DRUG
Ciprofloxacin Tablets USP, are available as white, round, film-coated tablets containing 250 mg ciprofloxacin. The 250 mg tablet is coded with "WW927" on one side. Ciprofloxacin Tablets, USP area also available as white, capsule shaped, film-coated tablets containing 500 mg or 750 mg ciprofloxacin. The 500 mg tablet is coded with "WW928" on one side. The 750 mg tablet is coded with "WW929" on one side. Ciprofloxacin Tablets, USP 250 mg and 500 mg are available in bottles of 30's, 100's and 500's. Ciprofloxacin Tablets, USP 750 mg are available in bottles of 50's and 100's and Unit Dose Boxes of 100 tablets. Strength Tablet Identification Bottles of 30's: 250 mg WW927 500 mg WW928 Bottles of 50's: 750 mg WW929 Bottles of 100's: 250 mg WW927 500 mg WW928 750 mg WW929 Bottles of 500's: 250 mg WW927 500 mg WW928 Unit Dose Boxes of 100 250 mg WW927 500 mg WW928 750 mg WW929 Store at 20-25°C (68-77°F) [See USP Controlled Room Temperature]. Dispense in a well-closed container as defined in the USP using a child-resistant closure.
Abbreviated New Drug Application
CIPROFLOXACIN - CIPROFLOXACIN TABLET, FILM COATED STAT RX USA LLC ---------- MEDICATION GUIDE Ciprofloxacin Tablets, USP Read the Medication Guide that comes with Ciprofloxacin Tablets before you start taking it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking to your healthcare provider about your medical condition or your treatment. WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT CIPROFLOXACIN TABLETS? Ciprofloxacin Tablets belong to a class of antibiotics called fluoroquinolones. Ciprofloxacin Tablets can cause side effects that may be serious or even cause death. If you get any of the following serious side effects, get medical help right away. Talk with your healthcare provider about whether you should continue to take Ciprofloxacin Tablets. Tendon rupture or swelling of the tendon (tendinitis) • Tendons are tough cords of tissue that connect muscles to bones. • Pain, swelling, tears, and inflammation of tendons including the back of the ankle (Achilles), shoulder, hand, or other tendon sites can happen in people of all ages who take fluoroquinolone antibiotics, including Ciprofloxacin Tablets. The risk of getting tendon problems is higher if you: • are over 60 years of age • are taking steroids (corticosteroids) • have had a kidney, heart, or lung transplant. Swelling of the tendon (tendinitis) and tendon rupture (breakage) have also happened in patients who take fluoroquinolones who do not have the above risk factors. • Other reasons for tendon ruptures can include: • physical activity or exercise • kidney failure • tendon problems in the past, such as in people with rheumatoid arthritis (RA) • Call your healthcare provider right away at the first sign of tendon pain, swelling or inflammation. Stop taking Ciprofloxacin Tablets until tendinitis or tendon rupture has been ruled out by your healthcare provider. Avoid exercise and using the affected area. The most common area of pain and swelling is the Achille Leia o documento completo
CIPROFLOXACIN - CIPROFLOXACIN TABLET, FILM COATED STAT RX USA LLC ---------- WARNING FLUOROQUINOLONES, INCLUDING CIPROFLOXACIN TABLETS, ARE ASSOCIATED WITH AN INCREASED RISK OF TENDINITIS AND TENDON RUPTURE IN ALL AGES. THIS RISK IS FURTHER INCREASED IN OLDER PATIENTS USUALLY OVER 60 YEARS OF AGE, IN PATIENTS TAKING CORTICOSTEROID DRUGS, AND IN PATIENTS WITH KIDNEY, HEART OR LUNG TRANSPLANTS (SEE WARNINGS). FLUOROQUINOLONES, INCLUDING CIPROFLOXACIN TABLETS, MAY EXACERBATE MUSCLE WEAKNESS IN PERSONS WITH MYASTHENIA GRAVIS. AVOID CIPROFLOXACIN TABLETS IN PATIENTS WITH KNOWN HISTORY OF MYASTHENIA GRAVIS. (SEE WARNINGS). To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ciprofloxacin Tablets and other antibacterial drugs, Ciprofloxacin Tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Ciprofloxacin Tablets, USP is a synthetic broad spectrum antimicrobial agent for oral administration. Ciprofloxacin hydrochloride, USP, a fluoroquinolone, is the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid. It is a faintly yellowish to light yellow crystalline substance with a empirical weight of 385.8. Its molecular formula is C H FN O •HCl•H O and its chemical structure is as follows: Ciprofloxacin film-coated tablets are available in 250 mg, 500 mg, and 750 mg (ciprofloxacin equivalent) strengths. Ciprofloxacin tablets are white to slightly yellowish. The inactive ingredients are colloidal silicon dioxide, corn starch, hydrogenated vegetable oil, hypromellose, magnesium stearate, microcrystalline cellulose, polyacrylate dispersion (methylacrylate and ethylacrylate copolymer), polyethylene glycol, purified water, simethicone emulsion, sodium starch glycolate, talc, and titanium dioxide. CLINICAL PHARMACOLOGY ABS ORPTION Ciprofloxacin given as an oral tablet is rapidly and well absorbed from the gastrointestinal tract after oral admi Leia o documento completo